Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction
Dongryul Oh, Hee Chul Park, Ho Yeong Lim, Byung Chul Yoo
Radiat Oncol J. 2013;31(3):171-174.   Published online 2013 Sep 30     DOI: https://doi.org/10.3857/roj.2013.31.3.171
Citations to this article as recorded by Crossref logo
Hematuria induced by combination regorafenib and hyperthermia – a radiation recall effect
Yu-Mei Zheng, Jyh-Ming Chow, Chia-Lun Chang, Liang-Hsiao Chao, Jacqueline Whang-Peng, Gi-Ming Lai
International Journal of Hyperthermia.2019; 36(1): 1185.     CrossRef
Radiation Recall Dermatitis in Patients Treated with Sorafenib
Keyur Mehta, Andreas Kaubisch, Justin Tang, Aneesh Pirlamarla, Shalom Kalnicki
Case Reports in Oncological Medicine.2018; 2018: 1.     CrossRef
Reacciones cutáneas a fármacos en el paciente con leucemia/linfoma
Mar Llamas-Velasco, Pedro Rodríguez-Jiménez, Pablo Chicharro, Javier Sánchez-Pérez
Piel.2017; 32(9): 548.     CrossRef
Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment
Francesco Borgia, Carlo Saitta, Mario Vaccaro, Maria Stella Franzè, Maria Lentini, Serafinella Patrizia Cannavò
International Journal of Immunopathology and Pharmacology.2017; 30(3): 327.     CrossRef
Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma
Gwi Eon Kim, Hee-Sung Song, Ki Jung Ahn, Young Suk Kim
Radiation Oncology Journal.2017; 35(3): 289.     CrossRef
Radiation recall dermatitis induced by sorafenib
Sonja Stieb, Oliver Riesterer, Cornelia Brüssow, Bernhard Pestalozzi, Matthias Guckenberger, Stefan Weiler
Strahlentherapie und Onkologie.2016; 192(5): 342.     CrossRef
Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients
Olivier Huillard, Emilie Boissier, Benoit Blanchet, Audrey Thomas-Schoemann, Anatole Cessot, Pascaline Boudou-Rouquette, Jean-Philippe Durand, Romain Coriat, Julie Giroux, Jerome Alexandre, Michel Vidal, Francois Goldwasser
Expert Opinion on Drug Safety.2014; 13(5): 663.     CrossRef
Sorafenib
Reactions Weekly.2013; 1478(1): 34.     CrossRef